Beneficial Ownership Report

ASHLAND INC. Filed 2025-01-31 Acc 0000902664-25-000618

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

2026-05-06 SCHEDULE 13D/A Beneficial Ownership Report
2025-02-03 4 Chair of the Board and CEO bought 31,294 shares at $64.24 ($2,010,327)
2025-02-03 4 SVP and GM, Life Sciences bought 3,150 shares at $64.00 ($201,600)
2025-01-31 SCHEDULE 13D/A Beneficial Ownership Report
2025-01-29 10-Q Quarterly Report
2025-01-28 8-K Results of operations · Regulation FD disclosure
2025-01-24 4 Director acquired 1,931 shares (option exercise)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…